Dark Mode Light Mode

What are You Looking For?

Popular Searches

Target Enrollment Completed for Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder psychiatrictimes

September 4, 2025

September 4, 2025

Add a comment Add a comment

Leave a Reply Cancel reply

Previous Post

The Violins and People of Hope and Labor psychiatrictimes

September 4, 2025

Next Post

Harnessing Neuroplasticity for Brain Injury Recovery psychiatrictimes

September 4, 2025

Recommended for You

Harnessing Neuroplasticity for Brain Injury Recovery psychiatrictimes

Polypharmacy in Patients Treated With Clozapine psychiatrictimes

Can Holograms of Hope for Genocides Also be Applicable to Psychiatry? psychiatrictimes

The August 2025 Special Report: Diversity psychiatrictimes

Contribution of Genetics, Environment, and Inflammation to Development of Severe Mental Illness psychiatrictimes

Lifting Us Up From Our Human Abyss psychiatrictimes

FDA Releases Complete Response Letter on Declining MDMA-Assisted Therapy for PTSD psychiatrictimes

Study on Zervimesine for Alzheimer Disease Reaches Enrollment Target psychiatrictimes